Crossover study of (99m)Tc-TRODAT-1 SPECT and (18)F-FDOPA PET in Parkinson's disease patients.

  title={Crossover study of (99m)Tc-TRODAT-1 SPECT and (18)F-FDOPA PET in Parkinson's disease patients.},
  author={Wen-Sheng Huang and Yung-Hsiao Chiang and J C Lin and Yuan-Hwa Chou and Cheng-Yi Cheng and Ren-Shyan Liu},
  journal={Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  volume={44 7},
UNLABELLED 99mTc-TRODAT-1 ([2-[[2-[[[3-(4-chlorophenyl)-8-methyl-8-azabicyclo[3,2,1]oct-2-yl]methyl](2-mercaptoethyl)amino]ethyl]amino]ethanethiolato(3-)-N2,N2',S2,S2']oxo-[1R-(exo-exo)]) is a potential agent for dopamine transporter (DAT) SPECT, whereas 6-(18)F-fluoro-L-dopa ((18)F-FDOPA) PET has been used for the quantitative assessment of presynaptic nigrostriatal dopaminergic function. The current study investigated the relationship between the 2 imaging modalities in evaluating patients… CONTINUE READING
21 Citations
34 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 21 extracted citations


Publications referenced by this paper.
Showing 1-10 of 34 references

Early differential diagnosis of Parkinson’s disease with F-18-FDG and PET

  • D Eidelberg, JR Moeller, T Ishikawa
  • Neurology
  • 2004

A multicenter assessment of dopamine transporter im1004 THE JOURNAL OF NUCLEAR MEDICINE

  • Parkinson Study Group
  • 2003

Similar Papers

Loading similar papers…